Share this article
Share this article
EMERYVILLE, Calif., Dec. 16, 2020 /PRNewswire/ Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, successfully hosted the first session of its virtual investor mini-series themed Delivering on the Promise of Synthetic Biology.
This first session entitled
Science and Technology, Sustainable Solutions for a Healthier Planet was conducted via live webcast and teleconference yesterday, Tuesday, December 15, 2020 at 1:00pm ET (10:00 am PT). The session included a business update, a technology presentation and Q&A.
The webinar was well-attended with nearly 300 people participating. Speaking on behalf of Amyris during the event were John Melo, President and Chief Executive Officer; Han Kieftenbeld, Chief Financial Officer, and; Sunil Chandran, Senior Vice President, Research and Development